article thumbnail

Publicly Traded Hospice Companies Poised for Deals

Hospice News

The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Case in point, VITAS Healthcare, a subsidiary of Chemed Corp.

article thumbnail

As Headwinds Rage, Large Hospice Companies Lay Groundwork for Potential 2023 Growth

Hospice News

This initiative is one example of investments and programs that companies are implementing this year that leaders expect to bear fruit in Q4 or next year. Another is the company-wide integration of Homecare Homebase at Aveanna Healthcare Holdings (NASDAQ: AVAH). In September, we eliminated approximately $6.5